Traws Pharma Inc. (TRAW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Traws Pharma Inc.

    NASDAQ: TRAW · Real-Time Price · USD
    1.85
    -0.03 (-1.60%)
    At close: Sep 26, 2025, 3:57 PM
    1.89
    2.06%
    After-hours: Sep 26, 2025, 07:04 PM EDT

    Traws Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 226K 226K 226K 226K
    Cost of Revenue
    		 12K 16K 14K 14K
    Gross Profit
    		 214K 210K 212K 212K
    Operating Income
    		 -49.35M -20.3M -19.63M -16.5M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -166.52M -18.95M -18.96M -16.16M
    Net Income
    		 -54.67M -18.95M -18.96M -16.16M
    Selling & General & Admin
    		 12.29M 9.09M 8.45M 9.43M
    Research & Development
    		 130.31M 11.41M 11.39M 7.28M
    Other Expenses
    		 -93.04M n/a n/a n/a
    Operating Expenses
    		 49.56M 20.51M 19.84M 16.71M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 49.57M 20.52M 19.85M 16.72M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 1.55M 839.55K 836.33K 673.29K
    Shares Outstanding (Diluted)
    		 1.55M 839.55K 836.33K 673.29K
    EPS (Basic)
    		 -35.21 -22.57 -22.68 -24.01
    EPS (Diluted)
    		 -35.21 -22.57 -22.68 -24.01
    EBITDA
    		 -166.51M -18.93M -18.95M -16.15M
    EBIT
    		 -166.52M -18.95M -18.96M -16.16M
    Depreciation & Amortization
    		 12K 16K 14K 14K

    Add to Watchlist